Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $208.62 USD
Change Today -0.85 / -0.41%
Volume 925.7K
ILMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 8:10 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Matthew L. Posard

Former Senior Vice President and General Manager of Translational & Consumer Genomics, Illumina Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 3 different industries.

See Board Relationships
47--

Background*

Mr. Matthew L. Posard, also known as Matt, has been the Chief Commercial Officer and Executive Vice President at TrovaGene, Inc. since March 2015. Mr. Posard served as Senior Vice President and General Manager of Translational & Consumer Genomics at Illumina Inc. He served as Vice President of Marketing of Illumina Inc. since February 2006 and also served as General Manager of new and emerging market opportunities business. Mr. Posard was responsible for all worldwide ...

Read Full Background

Corporate Headquarters*

5200 Illumina Way
San Diego, California 92122

United States

Phone: 858-202-4500
Fax: 858-202-4766

Board Members Memberships*

2013-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
University of California - San Diego

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $208.62 USD -0.85

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David P. King Chairman and Chief Executive Officer
Laboratory Corp. of America Holdings
$1.0M
Gajus V. Worthington Co-Founder, Chief Executive Officer, President and Director
Fluidigm Corporation
$490.0K
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$660.0K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.